BioCentury
ARTICLE | Financial News

Cerulean amends IPO

April 7, 2014 7:00 AM UTC

Cerulean Pharma Inc., Cambridge, Mass. Business: Drug delivery, Cancer Date announced: 3/31/14 Type: IPO To be raised: Up to $74.8 million Shares: 5 million Price: $11-$13 Underwriters: Leerink Partne...